IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,365,477 | +433.4% | 61,617 | +163.6% | 0.00% | – |
| Q2 2023 | $443,500 | -43.5% | 23,379 | -53.8% | 0.00% | – |
| Q1 2023 | $785,194 | +46.5% | 50,625 | +66.3% | 0.00% | – |
| Q4 2022 | $536,124 | +379.9% | 30,434 | +50.1% | 0.00% | – |
| Q1 2022 | $111,721 | -46.5% | 20,276 | -17.3% | 0.00% | – |
| Q4 2021 | $209,000 | -1.4% | 24,511 | +0.4% | 0.00% | – |
| Q3 2021 | $212,000 | -10.5% | 24,424 | +9.0% | 0.00% | – |
| Q2 2021 | $237,000 | -34.9% | 22,413 | -1.2% | 0.00% | – |
| Q1 2021 | $364,000 | -65.2% | 22,679 | +0.2% | 0.00% | -100.0% |
| Q4 2020 | $1,045,000 | +55.3% | 22,628 | +18.4% | 0.00% | 0.0% |
| Q3 2020 | $673,000 | +137.8% | 19,117 | +72.0% | 0.00% | – |
| Q2 2020 | $283,000 | – | 11,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |